Phase 1 Study for IPG11406 in Health Volunteer

Clinical trial NCT06255834 · COMPLETED

Trial details

NCT number: NCT06255834
Sponsor: Nanjing Immunophage Biotech Co., Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Inflammatory Bowel Diseases

Start date: 2024-02-24
Primary completion: 2024-12-30
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.